PODD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,354.77 -- higher than 97.45% of US-listed equities with positive expected earnings growth.
With a price/earnings ratio of 827.55, Insulet Corp P/E ratio is greater than that of about 99.13% of stocks in our set with positive earnings.
The price/operating cash flow metric for Insulet Corp is higher than 97.63% of stocks in our set with a positive cash flow.
If you're looking for stocks that are quantitatively similar to Insulet Corp, a group of peers worth examining would be ENTG, SCL, SUPN, MKSI, and LOGI.
Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company was founded in 2000 and is based in Billerica, Massachusetts.
Global Insulin Pumps Market has been brewing up and influencing the international economy with respect to revenue, growth rate, sale, market share, and size. The Global Insulin Pumps Market research report provides a rational explanation to the reader to understand
Insulet (PODD) announces that it has launched its Omnipod DASH System in Sweden, Finland, Norway and Denmark, and will add France, Belgium, Germany, Austria, Switzerland and Israel in the coming weeks.It previously launched the device, which provides up to three days on continuous insulin delivery, in the U.S., UK, the...